CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice

Immunology

Volumn 121, Issue 4, 2007, Pages 518-528

  Coles, Barbara ^a   Lewis, Ruth ^a   Anning, Peter B ^a   Morton, Jonathan ^a   Baalasubramanian, Sivasankar ^a   Morgan, B Paul ^a   O'Donnell, Valerie B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Angiotensin; CD59a; Complement; Hypertension; Vascular

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; CD31 ANTIGEN; CD59 ANTIGEN; COMPLEMENT COMPONENT C3; CYCLIC GMP; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HYPERTENSION; HYPERTROPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; VASCULAR RING;

EID: 34447094566     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02598.x     Document Type: Article

References (25)

1. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 101 : 1767 72.
2. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998 98 : 839 44.
3. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998 351 : 88 92.
4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 342 : 836 43.
5. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998 97 : 2007 11.
6. Roivainen M, Viik-Kajander M, Palosuo T et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000 101 : 252 7.
7. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999 106 : 506 12.
8. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998 31 : 1460 5.
9. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. Jama 2001 286 : 2107 13.
10. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000 343 : 1139 47.
11. Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 2005 25 : 1225 30.
12. Oroszlan M, Herczenik E, Rugonfalvi-Kiss S et al. Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP. Int Immunol 2006 18 : 871 8.
13. Lafuente N, Azcutia V, Matesanz N, Cercas E, Rodriguez-Manas L, Sanchez-Ferrer CF, Peiro C. Evidence for sodium azide as an artifact mediating the modulation of inducible nitric oxide synthase by C-reactive protein. J Cardiovasc Pharmacol 2005 45 : 193 6.
14. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Volta U, Puddu GM, Puddu P. Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol 1998 53 : 345 54.
15. Tomaszewski M, Zukowska-Szczechowska E, Grzeszczak W. [Evaluation of complement component C4 concentration and immunoglobulins IgA, IgG, and IgM in serum of patients with primary essential hypertension]. Pol Arch Med Wewn 2000 103 : 247 51.
16. Shagdarsuren E, Wellner M, Braesen JH et al. Complement activation in angiotensin II-induced organ damage. Circ Res 2005 97 : 716 24.
17. Lin ZH, Fukuda N, Jin XQ et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 2004 44 : 42 7.
18. Jones J, Laffafian I, Morgan BP. Purification of C8 and C9 from rat serum. Complement Inflamm 1990 7 : 42 51.
19. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 2001 98 : 442 9.
20. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 1995 92 : 11490 4.
21. Schmidt H, Kelm M. Determination of nitrite and nitrate by the Griess reaction. In : Stamler F, Feelisch M, eds. Methods in Nitric Oxide Research. London : Wiley, 1996 : 491 8.
22. Baalasubramanian S, Harris CL, Donev RM, Mizuno M, Omidvar N, Song WC, Morgan BP. CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol 2004 173 : 3684 92.
23. Schmiedt W, Kinscherf R, Deigner HP et al. Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998 18 : 1790 5.
24. Patel S, Thelander EM, Hernandez M et al. ApoE (-/-) mice develop atherosclerosis in the absence of complement component C5. Biochem Biophys Res Commun 2001 286 : 164 70.
25. Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, Lichtman AH. Influence of C3 deficiency on atherosclerosis. Circulation 2002 105 : 3025 31.